Amusing: one of the analysts on ZGEN’s CC asked why ZGEN had not submitted the fill/finish data from Raytheon earlier in the FDA’s review of the BLA so that there would not have been a delay for the FDA to have time to examine these data.
Quiz: What company should the analyst have been asking about instead of Raytheon?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”